15 results
424B5
EQ
Equillium Inc
5 Oct 23
Prospectus supplement for primary offering
5:23pm
supplement, the warrants and warrant agreements, and any claim, controversy or dispute arising under or related to the warrants or warrant agreements
425
EQ
Equillium Inc
6 Sep 22
Business combination disclosure
4:33pm
THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH SUCH PARTY HEREBY
8-K
EX-2.1
EQ
Equillium Inc
6 Sep 22
Equillium to Acquire Metacrine in All-Stock Transaction
4:29pm
be permitted by Law, shall be valid and sufficient service thereof.
(b) EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER
424B5
f0sdhk e6w
4 Feb 21
Prospectus supplement for primary offering
8:07am
424B5
kqfyo9gm6t99f2xd95
14 Aug 20
Prospectus supplement for primary offering
4:45pm
424B5
ua7 1rtutmi
13 Aug 20
Prospectus supplement for primary offering
4:04pm
424B5
hfmf7wd
14 Jul 20
Prospectus supplement for primary offering
6:05am
S-3
jrro0i
13 Nov 19
Shelf registration
5:20pm
S-3
EX-4.7
d32w1u8fr6
13 Nov 19
Shelf registration
5:20pm
S-3
EX-4.9
fhmiv ra21
13 Nov 19
Shelf registration
5:20pm
S-3
EX-4.8
4x2kj6idhgsb7e1i
13 Nov 19
Shelf registration
5:20pm
DRS
EX-10.7
jrq qmbgdepw5rgk
3 Aug 18
Draft registration statement
12:00am
DRS
EX-10.6
jt7lkpyow70k 4l
3 Aug 18
Draft registration statement
12:00am
- Prev
- 1
- Next